Zer En has an MSc in Public Health from King’s College London, and a Doctor of Medicine degree from China Medical University. He has had clinical experience across a wide range of medical specialties and has utilized his medical knowledge in the field of research at Hanson Wade. As the research analyst for the Checkpoint module at Beacon Targeted Therapies, Zer En is equipped to offer insights about checkpoint drug development, based on his background in medicine and public health. His research work includes a systematic review and meta-analysis of digital health interventions for hypertension management. Zer En is also multilingual, with fluency in English, Mandarin, and Malay, which enables him to work in a diverse, international environment.